Report Detail

Medical Devices & Consumables Global Sexually Transmitted Diseases (STD) Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4661369
  • |
  • 31 December, 2025
  • |
  • Global
  • |
  • 98 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our latest research, the global Sexually Transmitted Diseases (STD) Diagnostics market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.

This report is a detailed and comprehensive analysis for global Sexually Transmitted Diseases (STD) Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Sexually Transmitted Diseases (STD) Diagnostics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Sexually Transmitted Diseases (STD) Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Sexually Transmitted Diseases (STD) Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Sexually Transmitted Diseases (STD) Diagnostics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sexually Transmitted Diseases (STD) Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sexually Transmitted Diseases (STD) Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Sexually Transmitted Diseases (STD) Diagnostics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Molecular Test
Serologic Test
Point of Care Test
Others
Market segment by Application
Hospital
Clinic
Others
Market segment by players, this report covers
F.Hoffmann-La Roche Ltd
Thermo Fisher Scientific Inc.
Hologic Inc.
Creative Diagnostics
Abbott Laboratories
Quest Diagnostics
BD
QIAGEN
Cepheid
bioMerieux Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Sexually Transmitted Diseases (STD) Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Sexually Transmitted Diseases (STD) Diagnostics, with revenue, gross margin, and global market share of Sexually Transmitted Diseases (STD) Diagnostics from 2020 to 2025.
Chapter 3, the Sexually Transmitted Diseases (STD) Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Sexually Transmitted Diseases (STD) Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Sexually Transmitted Diseases (STD) Diagnostics.
Chapter 13, to describe Sexually Transmitted Diseases (STD) Diagnostics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Sexually Transmitted Diseases (STD) Diagnostics by Type
    • 1.3.1 Overview: Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Sexually Transmitted Diseases (STD) Diagnostics Consumption Value Market Share by Type in 2024
    • 1.3.3 Molecular Test
    • 1.3.4 Serologic Test
    • 1.3.5 Point of Care Test
    • 1.3.6 Others
  • 1.4 Global Sexually Transmitted Diseases (STD) Diagnostics Market by Application
    • 1.4.1 Overview: Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size & Forecast
  • 1.6 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region, (2020-2031)
    • 1.6.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.6 South America Sexually Transmitted Diseases (STD) Diagnostics Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 F.Hoffmann-La Roche Ltd
    • 2.1.1 F.Hoffmann-La Roche Ltd Details
    • 2.1.2 F.Hoffmann-La Roche Ltd Major Business
    • 2.1.3 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.1.4 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 F.Hoffmann-La Roche Ltd Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific Inc.
    • 2.2.1 Thermo Fisher Scientific Inc. Details
    • 2.2.2 Thermo Fisher Scientific Inc. Major Business
    • 2.2.3 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.2.4 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
  • 2.3 Hologic Inc.
    • 2.3.1 Hologic Inc. Details
    • 2.3.2 Hologic Inc. Major Business
    • 2.3.3 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.3.4 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Hologic Inc. Recent Developments and Future Plans
  • 2.4 Creative Diagnostics
    • 2.4.1 Creative Diagnostics Details
    • 2.4.2 Creative Diagnostics Major Business
    • 2.4.3 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.4.4 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Creative Diagnostics Recent Developments and Future Plans
  • 2.5 Abbott Laboratories
    • 2.5.1 Abbott Laboratories Details
    • 2.5.2 Abbott Laboratories Major Business
    • 2.5.3 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.5.4 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.6 Quest Diagnostics
    • 2.6.1 Quest Diagnostics Details
    • 2.6.2 Quest Diagnostics Major Business
    • 2.6.3 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.6.4 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.7 BD
    • 2.7.1 BD Details
    • 2.7.2 BD Major Business
    • 2.7.3 BD Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.7.4 BD Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 BD Recent Developments and Future Plans
  • 2.8 QIAGEN
    • 2.8.1 QIAGEN Details
    • 2.8.2 QIAGEN Major Business
    • 2.8.3 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.8.4 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 QIAGEN Recent Developments and Future Plans
  • 2.9 Cepheid
    • 2.9.1 Cepheid Details
    • 2.9.2 Cepheid Major Business
    • 2.9.3 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.9.4 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Cepheid Recent Developments and Future Plans
  • 2.10 bioMerieux Inc.
    • 2.10.1 bioMerieux Inc. Details
    • 2.10.2 bioMerieux Inc. Major Business
    • 2.10.3 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Product and Solutions
    • 2.10.4 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 bioMerieux Inc. Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Sexually Transmitted Diseases (STD) Diagnostics by Company Revenue
    • 3.2.2 Top 3 Sexually Transmitted Diseases (STD) Diagnostics Players Market Share in 2024
    • 3.2.3 Top 6 Sexually Transmitted Diseases (STD) Diagnostics Players Market Share in 2024
  • 3.3 Sexually Transmitted Diseases (STD) Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Sexually Transmitted Diseases (STD) Diagnostics Market: Region Footprint
    • 3.3.2 Sexually Transmitted Diseases (STD) Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Sexually Transmitted Diseases (STD) Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Sexually Transmitted Diseases (STD) Diagnostics Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Type (2020-2031)
  • 6.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2020-2031)
  • 6.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country
    • 6.3.1 North America Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Country (2020-2031)
    • 6.3.2 United States Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Type (2020-2031)
  • 7.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Application (2020-2031)
  • 7.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country
    • 7.3.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.3 France Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Region (2020-2031)
    • 8.3.2 China Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.5 India Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Type (2020-2031)
  • 9.2 South America Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Application (2020-2031)
  • 9.3 South America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country
    • 9.3.1 South America Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Sexually Transmitted Diseases (STD) Diagnostics Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Sexually Transmitted Diseases (STD) Diagnostics Market Drivers
  • 11.2 Sexually Transmitted Diseases (STD) Diagnostics Market Restraints
  • 11.3 Sexually Transmitted Diseases (STD) Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Sexually Transmitted Diseases (STD) Diagnostics Industry Chain
  • 12.2 Sexually Transmitted Diseases (STD) Diagnostics Upstream Analysis
  • 12.3 Sexually Transmitted Diseases (STD) Diagnostics Midstream Analysis
  • 12.4 Sexually Transmitted Diseases (STD) Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Sexually Transmitted Diseases (STD) Diagnostics. Industry analysis & Market Report on Sexually Transmitted Diseases (STD) Diagnostics is a syndicated market report, published as Global Sexually Transmitted Diseases (STD) Diagnostics Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Sexually Transmitted Diseases (STD) Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report